Biomolecular diagnosis of myotonic dystrophy type 2: a challenging approach
- 26 May 2017
- journal article
- review article
- Published by Springer Nature in Journal of Neurology
- Vol. 264 (8) , 1705-1714
Abstract
Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are the most common adult form of muscular dystrophy, characterized by autosomal dominant progressive myopathy, myotonia, and multiorgan involvement. The onset and symptoms of the myotonic dystrophies are diverse, complicating their diagnoses and limiting a comprehensive approach to their clinical care. Diagnostic delay in DM2 is due not only to the heterogeneous phenotype and the aspecific onset but also to the unfamiliarity with the disorder by most clinicians. Moreover, the DM2 diagnostic odyssey is complicated by the difficulties to develop an accurate, robust, and cost-effective method for a routine molecular assay. The aim of this review is to underline by challenging approach the diagnostic limits and pitfalls that could results in failure to recognize the presence of DM2 disease. Understanding and preventing delays in DM2 diagnosis may facilitate family planning, improve symptom management in the short term, and facilitate more specific treatment in the long term.Keywords
This publication has 78 references indexed in Scilit:
- Deregulated MicroRNAs in Myotonic Dystrophy Type 2PLOS ONE, 2012
- The Unstable CCTG Repeat Responsible for Myotonic Dystrophy Type 2 Originates from an AluSx Element Insertion into an Early Primate GenomePLOS ONE, 2012
- Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2European Journal of Human Genetics, 2012
- Severe Dilated Cardiomyopathy in a Patient With Myotonic Dystrophy Type 2 and Homozygous Repeat Expansion in ZNF9Congestive Heart Failure, 2011
- Fiber Types in Mammalian Skeletal MusclesPhysiological Reviews, 2011
- Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in FinlandEuropean Journal of Human Genetics, 2011
- Non-ATG–initiated translation directed by microsatellite expansionsProceedings of the National Academy of Sciences, 2010
- Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patientsJournal of Translational Medicine, 2010
- Premutation allele pool in myotonic dystrophy type 2Neurology, 2009
- Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophyThe EMBO Journal, 2000